Emapalumab Use in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: the REAL‐HLH Study

Chandrakasan, S., Allen, C. E., Bhatla, D., Carter, J., Chien, M., Cooper, R., Draper, L., Eckstein, O. S., Hanna, R., Hays, J. A., Hermiston, M. L., Hinson, A. P., Hobday, P. M., Isakoff, M. S., Jordan, M. B., Leiding, J. W., Modica, R., Nakano, T. A., … Oladapo, A. (2024). Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis & Rheumatology. Portico. https://doi.org/10.1002/art.42985

Authors:

Shanmuganathan Chandrakasan

Carl E. Allen

Deepika Bhatla

John Carter

May Chien

Robert B. Cooper

Lauren Draper

Olive S. Eckstein

Rabi Hanna

J. Allyson Hays

Michelle L. Hermiston